Lannett Company

With three facilities in Philadelphia, PA, Lannett Company, Inc. manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Our portfolio consists of numerous products across a wide range of therapeutic areas. We believe that our ability to select viable products for development, efficiently develop such products, including obtaining any applicable regulatory approvals, vertically integrate ourselves into certain specialty markets and achieve economies in production are all critical for our success in the generic pharmaceutical industry in which we operate.

Having cultivated strong and dependable customer relationships by maintaining adequate inventory levels and demonstrating a responsive order filling system, we take pride in our ability to satisfy our customer’s needs. Our dedicated employees strive to position Lannett as an industry leader that is focused on quality and integrity, as well as giving back to the community we serve. Lannett has a history of supporting schools, hospitals, veterans and their families, institutions, rehabilitation centers, cancer research, as well as the local fire and police departments.
Type
Public
HQ
Philadelphia, US
Founded
1942
Size (employees)
1,149 (est)
Lannett Company was founded in 1942 and is headquartered in Philadelphia, US

Lannett Company Office Locations

Lannett Company has offices in Philadelphia, Charlotte, Carmel-by-the-Sea, Dallas and in 13 other locations
Philadelphia, US (HQ)
13200 Townsend Rd
Show all (17)

Lannett Company Data and Metrics

Lannett Company Financial Metrics

Lannett Company's revenue was reported to be $165.7 m in Q3, 2017
USD

Revenue (Q3, 2017)

165.7 m

Gross profit (Q3, 2017)

84.2 m

Gross profit margin (Q3, 2017), %

51%

Net income (Q3, 2017)

(6.3 m)

EBIT (Q3, 2017)

43.6 m

Market capitalization (21-Jul-2017)

824.9 m

Cash (31-Mar-2017)

132 m
Lannett Company's current market capitalization is $824.9 m.
USDFY, 2014FY, 2015FY, 2016

Revenue

273.8 m406.8 m542.5 m

Revenue growth, %

49%33%

Cost of goods sold

99.3 m100.5 m237.4 m

Gross profit

174.5 m306.4 m305.1 m

Gross profit Margin, %

64%75%56%

R&D expense

45.1 m

General and administrative expense

68.3 m

Operating expense total

66.3 m79.9 m155.7 m

EBIT

88.1 m226.5 m130.8 m

EBIT margin, %

32%56%24%

Interest expense

130 k207 k65.9 m

Pre tax profit

90 m227.4 m62.2 m

Income tax expense

32.9 m77.4 m17.3 m

Net Income

57.2 m150 m44.9 m
USDQ1, 2014Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017

Revenue

93.4 m114.8 m99.4 m106.4 m127.1 m163.7 m161.6 m170.9 m165.7 m

Cost of goods sold

21.8 m27.6 m23.7 m28.8 m51.8 m75.3 m70.8 m75.2 m81.6 m

Gross profit

71.6 m87.2 m75.6 m77.6 m75.3 m88.4 m90.7 m95.8 m84.2 m

Gross profit Margin, %

77%76%76%73%59%54%56%56%51%

R&D expense

6.4 m7.8 m9.2 m6.5 m9.1 m16.5 m12.4 m9.9 m8.3 m

General and administrative expense

15.5 m14.7 m16.2 m21.3 m18.1 m17.6 m

Operating expense total

6.4 m7.8 m9.2 m22.1 m23.7 m32.7 m33.6 m28 m26 m

EBIT

54.7 m66.5 m54.3 m51.4 m30.3 m18.6 m(20.3 m)34.3 m43.6 m

EBIT margin, %

59%58%55%48%24%11%(13%)20%26%

Interest expense

(38 k)(73 k)(8 k)(60 k)(11.8 m)(27 m)(23 m)(23.3 m)(22.4 m)

Pre tax profit

54.8 m67.3 m54.2 m50.3 m19.5 m(8.2 m)(42.3 m)11.7 m22.3 m

Income tax expense

19.8 m22.4 m18 m17.1 m6 m(2.7 m)(12.9 m)3.5 m7.3 m

Net Income

35 m79.8 m116 m33.2 m46.7 m41.3 m(29.4 m)(21.2 m)(6.3 m)
USDFY, 2014FY, 2015FY, 2016

Cash

105.6 m200.3 m224.8 m

Accounts Receivable

61.3 m91.1 m211.7 m

Inventories

44.8 m46.2 m114.9 m

Current Assets

265.5 m370.5 m612.8 m

PP&E

61.7 m94.6 m216.6 m

Goodwill

333.6 m

Total Assets

342.8 m508.8 m1.8 b

Accounts Payable

21 m19.2 m34.7 m

Total Debt

129 k135 k178.2 m

Current Liabilities

47 m44.1 m306.7 m

Total Liabilities

1.2 b

Common Stock

36 k37 k37 k

Additional Paid-in Capital

216.8 m236.2 m283.3 m

Retained Earnings

83.7 m233.6 m278.4 m

Total Equity

294.8 m463.8 m554.5 m

Debt to Equity Ratio

0 x0 x0.3 x

Debt to Assets Ratio

0 x0 x0.1 x

Financial Leverage

1.2 x1.1 x3.2 x
USDQ1, 2014Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017

Cash

137.4 m170.6 m208.8 m207.8 m178.8 m225.4 m241.7 m247.3 m132 m

Accounts Receivable

75.8 m90.6 m79.7 m107.2 m235 m183.6 m190.5 m223 m215.2 m

Inventories

44.1 m42.6 m42.5 m45.2 m124 m116.5 m127.8 m130.2 m123.8 m

Current Assets

287.8 m334 m367.2 m400.4 m607 m601.6 m646 m665.6 m554.7 m

PP&E

69.7 m75.3 m80.3 m98.6 m198.4 m220.2 m221.3 m227.1 m232.3 m

Goodwill

141 k240.7 m313.5 m339.6 m339.6 m339.6 m

Total Assets

374 m423.7 m463.1 m543 m1.8 b1.8 b1.7 b1.8 b1.6 b

Accounts Payable

14 m19 m17 m17.3 m33.5 m33 m44 m43.8 m48.8 m

Current Liabilities

40.4 m43.2 m34.9 m40.3 m146.9 m176.9 m312.5 m332.7 m210.9 m

Common Stock

36 k36 k37 k37 k37 k37 k37 k37 k37 k

Additional Paid-in Capital

219.7 m222.1 m233.5 m242 m276.2 m279.9 m287.8 m288.9 m291.2 m

Retained Earnings

118.6 m163.4 m199.6 m266.8 m280.3 m274.8 m248.9 m257.1 m272 m

Total Equity

332.6 m379.6 m427.2 m501.9 m549.7 m547.5 m527.7 m536.7 m553.9 m

Financial Leverage

1.1 x1.1 x1.1 x1.1 x3.2 x3.2 x3.3 x3.3 x2.9 x
USDFY, 2014FY, 2015FY, 2016

Net Income

57.2 m150 m44.9 m

Depreciation and Amortization

6 m5.6 m18.6 m

Accounts Receivable

(35 m)(25 m)15.1 m

Inventories

(12 m)1.4 m15.3 m

Accounts Payable

(1.7 m)(2.5 m)(3.7 m)

Cash From Operating Activities

45.1 m128.5 m135.3 m

Purchases of PP&E

(107.4 m)(95.7 m)(81.1 m)

Cash From Investing Activities

(56.4 m)(45.8 m)(959.1 m)

Long-term Borrowings

(5.4 m)(129 k)(295 m)

Cash From Financing Activities

74.2 m12.3 m848.2 m

Interest Paid

130 k206 k52.9 m

Income Taxes Paid

34.3 m75.6 m35.1 m
USDQ1, 2014Q2, 2014Q3, 2015Q1, 2015Q2, 2015Q3, 2016Q1, 2016Q2, 2016Q3, 2017

Net Income

35 m79.8 m116 m33.2 m46.7 m41.3 m(29.4 m)(21.2 m)(6.3 m)

Depreciation and Amortization

1.3 m2.6 m4 m1.9 m8.1 m20.1 m14.3 m28 m41.6 m

Accounts Receivable

(14.5 m)(29.3 m)(18.4 m)(16.1 m)5.3 m50.9 m15.2 m(17.2 m)(9.5 m)

Inventories

774 k2.2 m2.4 m960 k6 m13.3 m(12.8 m)(15.3 m)(8.9 m)

Accounts Payable

(7 m)(1.9 m)(4 m)(1.9 m)(4.9 m)(5.4 m)9.3 m9.1 m11.6 m

Cash From Operating Activities

14.4 m52.6 m89.7 m15.9 m61.6 m123.2 m36.4 m67.3 m120.5 m

Purchases of PP&E

(16.9 m)(43.8 m)(73.3 m)(28 m)(44.5 m)(64.2 m)(24.4 m)(54.2 m)(101.1 m)

Cash From Investing Activities

16.2 m10.6 m1.9 m(8.4 m)(941.1 m)(945.9 m)(6.4 m)(17.4 m)(38 m)

Long-term Borrowings

(32 k)(64 k)(96 k)(33 k)(22.8 m)(34.2 m)(13.3 m)(26.6 m)

Cash From Financing Activities

1.2 m2.1 m11.9 m1.2 m857.9 m847.8 m(13.1 m)(27.4 m)(175.3 m)

Interest Paid

25 k111 k123 k11 k5.6 m20.4 m17.4 m35 m51.4 m

Income Taxes Paid

11.8 m40.8 m60.8 m22.9 m35 m35.1 m12.8 m13.6 m
USDY, 2017

Revenue/Employee

144.2 k

Financial Leverage

2.9 x

Lannett Company Market Value History

Lannett Company News and Updates

Lannett Company Company Life and Culture

You may also be interested in